Demonstrates enhanced antibacterial activity of silver nanoparticles in bacteria, suggesting a green approach for antibiotic alternatives.
The green synthesis of silver nanoparticles (AgNPs) using plant extracts provides a non-toxic and sustainable alternative to conventional chemical methods. This study reports the novel biosynthesis of AgNPs using the leaf extract of Prosopis farcta as both a reducing and stabilizing agent. The formation of AgNPs was confirmed by UV-Vis spectroscopy (200–600 nm). Comprehensive characterization via FT-IR, FESEM, XRD, and DLS revealed that the synthesized nanoparticles were spherical with an average diameter of 39 nm ( p < 0.05) and high colloidal stability (zeta potential: -49.7 mV). The antibacterial efficacy of these AgNPs was evaluated against Escherichia coli and Staphylococcus aureus . Results demonstrated potent antibacterial activity, with a concentration of 15.3 µ g/mL producing a maximum inhibition zone of 14 ± 0.9 mm against Staphylococcus aureus . This efficacy is comparable to commercial antibiotics such as gentamicin and ciprofloxacin.
No takes yet. Share an insight, caveat, or question.
Asadi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: